arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Fortrea Holdings Inc.

FTRE
$20.47 ▼ -0.37 (-1.78%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
21 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
15
Health
Poor
Bearish
auto_awesome

Analytical Summary

Fortrea Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.0B
Dividend Yield —
Revenue Growth -1.4% ↗
Op. Margin 2.2% →
ROIC -0.2% ↘
FCF / Share $0.64 ↗
Trailing P/E 2047.0x
Price / Book 3.7x
FCF Yield 3.1%
Debt / Equity 1.94
info Valuation on last close. End-of-day price, Nov 5, 2026.

21-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$691.50M
↓ -1.4% —
Net Income Profit after all expenses
$-23.60M
↑ +95.8% —
Operating Margin Operating profit as % of sales
2.2%
↓ -0.6% 7th
FCF / Share Free cash flow per share
$0.64
↑ +108.6% —
Long-Term Debt Long-term obligations
$1.03B
↓ -0.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
18
Returns
4
Financial Health
22
Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 6 years · 21 quarters